European training network for development of personalized anti-infective medical devices combining printing technologies and antimicrobial functionality

The main aim of WP1 will be to identify and characterize novel anti-biofilm leads to be used on the printed devices and formulations that will be developed in WP2. The desired compound features for active leads will include: i) microbicidal activity and/or ii) prevention of biofilm formation. The starting collection will include known anti- biofilms that are currently being investigated such as Quorum Sensing Inhibitors (QSI) and Antimicrobial Peptides (AMP).